CALLIE CLEMENT: Open Payments
NPI 1790486512 · GADSDEN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$789 in 36 payments from 7 companies in 2025. Trend: 2023 $104 · 2024 $520 · 2025 $789
Food & beverage: $704Education: $85
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 23 | $476 |
| Janssen Biotech, Inc. | 5 | $156 |
| Astellas Pharma US Inc | 3 | $52 |
| Olympus America Inc. | 2 | $41 |
| Endo USA, Inc. | 1 | $26 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $20 |
| PFIZER INC. | 1 | $18 |
Products named: GEMTESA, ERLEADA, Xtandi, iTIND System, XIAFLEX, PYLARIFY.
Industry payments across AL — which companies pay providers there.
